POTASSIUM CHLORIDE- potassium chloride tablet, extended release United States - English - NLM (National Library of Medicine)

potassium chloride- potassium chloride tablet, extended release

nucare pharmaceuticals, inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium cation 20 meq - because of reports of intestinal and gastric ulceration and bleeding with controlled release potassium chloride preparations, these drugs should be reserved for those patients who cannot tolerate or refuse to take liquid or effervescent potassium preparations or for patients in whom there is a problem of compliance with these preparations. 1. for the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication, and in patients with hypokalemic familial periodic paralysis. if hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. 2. for the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, e.g. digitalized patients or patients with significant cardiac arrhythmias. the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patien

POTASSIUM CHLORIDE solution United States - English - NLM (National Library of Medicine)

potassium chloride solution

pharmaceutical associates, inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium chloride 3 g in 15 ml - 1. for the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication, and in patients with hypokalemic familial periodic paralysis. if hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. 2. for the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias. the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern, and when low doses of the diuretic are used. serum potassium should be checked periodically, however, and, if hypokalemia occurs, dietary supplementation with potassium-containing foods may be adequate to control milder cases. in more severe cases, and if dose adjustment of the diuretic is ineffective or unwar

Potassium chloride 10% (potassium 13.3mmol/10ml) solution for infusion 10ml ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 10% (potassium 13.3mmol/10ml) solution for infusion 10ml ampoules

potassium 13.3mmol/10ml) solution for infusion 10ml ampoules (martindale pharmaceuticals ltd - potassium chloride - solution for infusion - 100mg/1ml

Potassium chloride 15% (potassium 20mmol/10ml) solution for infusion 10ml ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 15% (potassium 20mmol/10ml) solution for infusion 10ml ampoules

potassium 20mmol/10ml) solution for infusion 10ml ampoules (martindale pharmaceuticals ltd - potassium chloride - solution for infusion - 150mg/1ml

Potassium chloride 0.15% (potassium 10mmol/500ml) / Glucose 4% / Sodium chloride 0.18% infusion 500ml bags United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 0.15% (potassium 10mmol/500ml) / glucose 4% / sodium chloride 0.18% infusion 500ml bags

potassium 10mmol/500ml) / glucose 4% / sodium chloride 0.18% infusion 500ml bags (baxter healthcare ltd - potassium chloride; glucose anhydrous; sodium chloride - infusion - 1.5mg/1ml ; 40mg/1ml ; 1.8mg/1ml

Potassium chloride 0.15% (potassium 10mmol/500ml) / Sodium chloride 0.9% infusion 500ml Viaflo bags United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 0.15% (potassium 10mmol/500ml) / sodium chloride 0.9% infusion 500ml viaflo bags

potassium 10mmol/500ml) / sodium chloride 0.9% infusion 500ml viaflo bags (baxter healthcare ltd - potassium chloride; sodium chloride - infusion - 1.5mg/1ml ; 9mg/1ml

Potassium chloride 0.3% (potassium 20mmol/500ml) / Sodium chloride 0.9% infusion 500ml Viaflo bags United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 0.3% (potassium 20mmol/500ml) / sodium chloride 0.9% infusion 500ml viaflo bags

potassium 20mmol/500ml) / sodium chloride 0.9% infusion 500ml viaflo bags (baxter healthcare ltd - potassium chloride; sodium chloride - infusion - 3mg/1ml ; 9mg/1ml

Potassium chloride 0.15% (potassium 20mmol/1litre) / Glucose 5% infusion 1litre Viaflo bags United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 0.15% (potassium 20mmol/1litre) / glucose 5% infusion 1litre viaflo bags

potassium 20mmol/1litre) / glucose 5% infusion 1litre viaflo bags (baxter healthcare ltd - potassium chloride; glucose anhydrous - infusion - 1.5mg/1ml ; 50mg/1ml

POTASSIUM CHLORIDE- potassium chloride tablet, extended release United States - English - NLM (National Library of Medicine)

potassium chloride- potassium chloride tablet, extended release

remedyrepack inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium chloride 10 meq - because of reports of intestinal and gastric ulceration and bleeding with controlled-release potassium chloride preparations, these drugs should be reserved for those patients who cannot tolerate or refuse to take liquid or effervescent potassium preparations or for patients in whom there is a problem of compliance with these preparations. - for the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication, and in patients with hypokalemic familial periodic paralysis. if hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. - for the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, eg, digitalized patients or patients with significant cardiac arrhythmias. the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have

POTASSIUM CHLORIDE tablet, extended release United States - English - NLM (National Library of Medicine)

potassium chloride tablet, extended release

cardinal health - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium chloride 1500 mg - because of reports of intestinal and gastric ulceration and bleeding with extended-release potassium chloride preparations, these drugs should be reserved for those patients who cannot tolerate or refuse to take liquid or effervescent potassium preparations or for patients in whom there is a problem of compliance with these preparations. the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern and when low doses of the diuretic are used. serum potassium should be checked periodically, however, and if hypokalemia occurs, dietary supplementation with potassium-containing foods may be adequate to control milder cases. in more severe cases, and if dose adjustment of the diuretic is ineffective or unwarranted, supplementation with potassium salts may be indicated. potassium supplements are contraindicated in patients with hyperkalemia since a further increase in serum potassium concentration in such pat